自助采样HPV DNA检测对新加坡基层宫颈癌筛查的影响:实用性随机对照试验
在新加坡基层医疗中开展实用性两臂随机对照试验(Zelen设计),纳入650名30-69岁应筛查女性,比较提供自助采样联合医生采样与仅医生采样的效果。结果显示干预组高危HPV检出率和筛查参与率均显著提高,但受教育程度较低者选择自助采样的比例较低。
要点
- 提供自助采样HPV DNA检测可显著提高宫颈癌筛查参与率(56.6% vs 42.8%)。
- 干预组高危HPV检出率显著高于常规护理组(3.1% vs 0.3%)。
- 受教育程度较低的女性选择自助采样的可能性较低,需针对性干预。
核心结论
- 在医生采样基础上提供自助采样HPV DNA检测可显著提高筛查参与率和高危HPV检出率。
- 受教育程度较低的女性筛查参与率仍较低,需要针对性动员策略。
研究设计与样本
- 实用性两臂随机对照试验,采用Zelen设计,在新加坡NHG综合诊所开展。
- 共650名30-69岁应筛查女性随机分组,640名纳入分析(每组320名)。
主要发现
- 干预组高危HPV检出率为3.1%,常规护理组为0.3%,绝对差异2.8%(95% CI 0.8-4.8,P < .001)。
- 干预组筛查参与率为56.6%,常规护理组为42.8%,绝对差异13.8%(95% CI 6.0-21.4,P < .001)。
- 筛查参与率的提高在定期筛查史女性和既往未筛查女性中均观察到。
- 干预组中接受筛查的参与者有56.4%选择自助采样。
- 受教育程度较低与选择自助采样而非拒绝筛查的 odds 较低相关。
临床怎么用
- 在基层宫颈癌筛查中可考虑提供自助采样HPV DNA检测作为医生采样的替代选择,以提高筛查参与率。
- 对受教育程度较低的女性应加强针对性健康教育 and 动员,以缩小筛查差异。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Singapore, cervical cancer screening rates remain suboptimal, with only clinician sampling included in the national screening program. Self-sampling human papillomavirus (HPV) DNA testing might overcome barriers to clinician-based screening and improve uptake. We assessed the effect of offering self-sampling alongside clinician sampling on screening uptake and high-risk HPV detection compared with clinician sampling alone. METHODS: This pragmatic, 2-arm randomized controlled trial with Zelen design was conducted across NHG Polyclinics, NHG Health in Singapore. Women aged 30-69 years due for cervical cancer screening were randomly assigned (1:1) to intervention (offered selection of clinician sampling followed by self-sampling) or usual care (clinician sampling alone). The primary outcome was high-risk HPV DNA detection, and the secondary outcome was screening uptake. We performed subgroup analysis to examine both outcomes by prior screening history. Multivariable analysis identified factors associated with screening choices. RESULTS: From August 2024 to February 2025, 650 women were randomized, and 640 were included in the analysis (320 per arm). Significantly more high-risk HPV was detected in the intervention arm (3.1% vs 0.3%; absolute difference 2.8%; 95% CI, 0.8-4.8;P < .001), driven by greater screening uptake (56.6% vs 42.8%; absolute difference 13.8%; 95% CI, 6.0-21.4; P < .001), particularly among women with regular screening history and those with no prior screening. Among screened participants in the intervention arm, 56.4% chose self-sampling. Lower educational attainment was associated with lower odds of choosing self-sampling over declining screening. CONCLUSIONS: Offering self-sampling HPV DNA testing alongside clinician sampling significantly increased screening uptake and high-risk HPV detection rates. However, uptake remained lower among women with less education, highlighting the need for targeted engagement strategies.Abstract also available in: عربي (Arabic); Deutsch (German); Español (Spanish); Francais (French); हिन्दी (Hindi); Indonesia (Indonesian); (Chinese); (Japanese); Portugues (Portuguese).
引用
- Ng XR, Quek IP, Pereira MJ, et al. Effect of Self-Sampling HPV DNA Testing on Cervical Cancer Screening in Singapore's Primary Care: Pragmatic Randomized Controlled Trial. Ann Fam Med. 2026. PMID: 42509175. doi:10.1370/afm.250683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。